They aim to tackle systematic bias, wastage, error, and fraud in research behind patient care Related items from OnMedica Financial ties between researchers and drug industry linked to positive trial results Statins might not cut colorectal cancer risk after all US expert group updates statins recommendations Public should ask GPs about drugs’ relative risks and benefits BMJ questions trial evidence for rivaroxaban |
No comments:
Post a Comment